Subvolts take AI is accelerating drug discovery, potentially leading to cures for all diseases. Jun 5, 2025
For you
Developers
Learn how AI models like AlphaFold 3 are applied to complex scientific research problems, potentially inspiring new applications.
Business
Understand how AI is revolutionizing drug discovery, leading to faster development cycles and new market opportunities in healthcare.
Everyday users
Discover how AI is being used to find cures for diseases, potentially leading to better and more personalized medical treatments in the future.
Hype note
3/5Notable

This episode features researchers from Isomorphic Labs discussing a significant AI advancement in drug discovery with AlphaFold 3.

Google DeepMind: The Podcast · Ep 18 Episode Official · Google

A Quest for a Cure: AI Drug Design with Isomorphic Labs

45 min Interview Hosts: Hannah Fry
0:0045:27

Audio streams from Hannah Fry. Your place is remembered on this device.

From Subvolts

Summary and analysis by Subvolts editorial, AI-assisted.

Summary

Google DeepMind: The Podcast features Max Jaderberg and Rebecca Paul of Isomorphic Labs discussing AI's role in drug discovery. They highlight AlphaFold 3's ability to predict molecular structures, accelerating the search for new treatments. The conversation covers drug design complexities, understanding diseases, overcoming toxicity, and developing cures for currently untreatable conditions, aiming for personalized medicine and universal treatments.

Explained simply

Scientists are using AI to understand the tiny building blocks of our bodies. This helps them design new medicines much faster, like finding the perfect key for a complex lock. It could lead to better treatments for many diseases, even those we can't cure today.

Why listen

This episode offers insight into how AI, specifically Google DeepMind's AlphaFold 3, is transforming pharmaceutical research. It's for anyone interested in the intersection of AI and medicine, from scientists to patients. Listeners will learn about the challenges in drug design and how AI provides solutions for faster, more effective treatments. This directly relates to Google's ongoing efforts in AI research and its application to real-world problems, showcasing a tangible benefit of their advanced AI models.

On the mic
  • HostHannah Fry
  • GuestMax JaderbergIsomorphic Labs
  • GuestRebecca PaulIsomorphic Labs
About
Key facts
  • Episode Title: A Quest for a Cure: AI Drug Design with Isomorphic Labs
  • Show: Google DeepMind: The Podcast
  • Length: 45 minutes
  • Key Technology: AlphaFold 3
  • Goal: Design treatments for all diseases
Show notes from Hannah Fry

In this episode, host Hannah Fry is joined by Max Jaderberg and Rebecca Paul of Isomorphic Labs to explore the future of drug discovery in the age of AI. They discuss how new technology, particularly AlphaFold 3, is revolutionizing the field by predicting the structure of life’s molecules, paving the way for faster and more efficient drug discovery.

They dig into the immense complexities of designing new drugs: How do you find the right molecular key for the right biological lock? How can AI help scientists understand disease better and overcome challenges like drug toxicity? And what about the diseases that are currently considered “undruggable”? Finally, they explore the ultimate impact of this technology, from the future of personalised medicine to the ambitious goal of being able to eventually design treatments for all diseases.

Further reading: 

  • AlphaFold 3: https://www.nature.com/articles/s41586-024-07487-w 
  • AlphaFold Server: https://alphafoldserver.com/ 
  • Isomorphic Labs: https://www.isomorphiclabs.com/ 
  • AlphaFold 3 code and weights: https://github.com/google-deepmind/alphafold3

Thanks to everyone who made this possible, including but not limited to: 

  • Presenter: Professor Hannah Fry 
  • Series Producer: Dan Hardoon 
  • Editor: Rami Tzabar 
  • Commissioner & Producer: Emma Yousif 
  • Music composition: Eleni Shaw 
  • Audio engineer: Richard Courtice 
  • Production Manager: Dan Lazard 
  • Studio Manager: Nicholas Duke 
  • Video Director: Bernardo Resende 
  • Video Editor: Bilal Merhi 
  • Audio Engineer: Perry Rogantin 
  • Camera and Lighting Operator: Robert Messere 
  • Production Coordination: Zoey Roberts, Sarah Ellen Morton 
  • Visual Identity and Design: Rob Ashley 
  • Commissioned by Google DeepMind

Please leave us a review on Spotify or Apple Podcasts if you enjoyed this episode. We always want to hear from our audience whether that's in the form of feedback, new idea or a guest recommendation!


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Jargon decoded
molecular key for the right biological lock
Max Jaderberg and Rebecca Paul
finding the right molecule to interact with a specific part of the body to create a desired effect
drug toxicity
Max Jaderberg and Rebecca Paul
how poisonous or harmful a drug can be
Published
Show
Google DeepMind: The Podcast · Hannah Fry
Length
45 min
Companies
Google
Products
AlphaFold 3
Summary by
Subvolts, using an AI model (how we work). Spotted a mistake? Tell us.

Same guests, other shows

Questions people ask

What is AlphaFold 3?
AlphaFold 3 is a new AI technology from Google DeepMind that predicts the structure of life's molecules, significantly aiding drug discovery.
How does AI help with drug discovery?
AI helps scientists understand disease better, find the right molecular keys for biological locks, and overcome challenges like drug toxicity, leading to faster and more efficient drug design.

Page generated Oct 19, 2026. Summaries are Subvolts' own; the audio, artwork and notes belong to Hannah Fry.